Literature DB >> 12835300

Study of viral integration of HPV-16 in young patients with LSIL.

G Gallo1, M Bibbo, L Bagella, A Zamparelli, F Sanseverino, M R Giovagnoli, A Vecchione, A Giordano.   

Abstract

AIMS: To investigate the physical status of human papillomavirus 16 (HPV-16) in low grade squamous intraepithelial lesions (LSILs) as a means of determining the percentage of viral integration.
METHODS: Ninety two LSIL/HPV positive Thin Prep(TM) samples were initially tested for the E6 gene by the polymerase chain reaction (PCR) to identify the HPV-16 virus. To avoid false positive results, the specificity of the bands obtained from PCR was confirmed by Southern blot hybridisation with internal oligonucleotide probes. Next, a PCR screen for the E2 gene was performed to identify those samples in which the virus was integrated. Viral integration was detected in just over half of them.
RESULTS: Twenty of the 92 samples were HPV-16 positive, as shown by PCR for the E6 gene. Southern blot analysis confirmed that 13 of these samples were positive for the viral E6 gene. Thus, viral integration was detected in just over a half of the samples positive for HPV-16.
CONCLUSIONS: These data show that HPV-16 integration occurs in a subset of LSILs. The measurement of HPV-16 integration would be a helpful complementary tool for cytological evaluation in primary cervical screening to identify those patients at risk of developing high grade squamous intraepithelial lesions and cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835300      PMCID: PMC1770000          DOI: 10.1136/jcp.56.7.532

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  55 in total

1.  Does HPV testing have a role in primary cervical screening?

Authors:  C S Herrington
Journal:  Cytopathology       Date:  2001-04       Impact factor: 2.073

2.  Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas.

Authors:  M Kalantari; E Blennow; B Hagmar; B Johansson
Journal:  Diagn Mol Pathol       Date:  2001-03

Review 3.  Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins.

Authors:  W Zwerschke; P Jansen-Dürr
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

4.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 5.  Molecular mechanism of carcinogenesis by human papillomavirus-16.

Authors:  T Ishiji
Journal:  J Dermatol       Date:  2000-02       Impact factor: 4.005

6.  Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways.

Authors:  S I Wells; D A Francis; A Y Karpova; J J Dowhanick; J D Benson; P M Howley
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

7.  Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.

Authors:  E C Thorland; S L Myers; D H Persing; G Sarkar; R M McGovern; B S Gostout; D I Smith
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

8.  Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening.

Authors:  Y L Oh; K J Shin; J Han; D S Kim
Journal:  Cytopathology       Date:  2001-04       Impact factor: 2.073

9.  Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing.

Authors:  M E Sherman; M Mendoza; K R Lee; R Ashfaq; G G Birdsong; M E Corkill; K M McIntosh; S L Inhorn; D J Zahniser; G Baber; C Barber; M H Stoler
Journal:  Mod Pathol       Date:  1998-09       Impact factor: 7.842

10.  Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women.

Authors:  C Clavel; M Masure; J P Bory; I Putaud; C Mangeonjean; M Lorenzato; P Nazeyrollas; R Gabriel; C Quereux; P Birembaut
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

View more
  16 in total

1.  p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.

Authors:  Giovanni Negri; Fabio Vittadello; Fabio Romano; Armin Kasal; Francesco Rivasi; Salvatore Girlando; Christine Mian; Eduard Egarter-Vigl
Journal:  Virchows Arch       Date:  2004-10-09       Impact factor: 4.064

2.  Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.

Authors:  Wendy Theelen; Ernst-Jan M Speel; Michael Herfs; Martin Reijans; Guus Simons; Els V Meulemans; Marcella M Baldewijns; Frans C S Ramaekers; Joan Somja; Philippe Delvenne; Anton H N Hopman
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

3.  Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

Authors:  Hugo Arias-Pulido; Cheri L Peyton; Nancy E Joste; Hernan Vargas; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Detection of HPV by in situ hybridization in thin-layer (ThinPrep) cervicovaginal samples.

Authors:  Francesc Alameda; Maria Luisa Mariñoso; Beatriz Bellosillo; Mercè Muset; Silvia Pairet; Imma Soler; Emilia Romero; Fernando Larrazabal; Ramon Carreras; Sergi Serrano
Journal:  Tumour Biol       Date:  2011-02-08

5.  Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

Authors:  S-M A Kulmala; S M Syrjänen; U B Gyllensten; I P Shabalova; N Petrovichev; P Tosi; K J Syrjänen; B C Johansson
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

6.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

7.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

8.  The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions.

Authors:  M I Zubillaga-Guerrero; B Illades-Aguiar; M A Leyva-Vazquez; E Flores-Alfaro; E Castañeda-Saucedo; J F Muñoz-Valle; L C Alarcón-Romero
Journal:  J Cytol       Date:  2013-01       Impact factor: 1.000

Review 9.  A review of methods for detect human Papillomavirus infection.

Authors:  André L P Abreu; Raquel P Souza; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Virol J       Date:  2012-11-06       Impact factor: 4.099

Review 10.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.